Thyroid functions in long-term survivors of pediatric hodgkin's lymphoma treated with chemotherapy and radiotherapy

JCRPE Journal of Clinical Research in Pediatric Endocrinology

Volumn 3, Issue 2, 2011, Pages 89-94

  Demirkaya, Metin ^a   Sevinir, Betül ^a   Saǧlam, Halil ^a   Özkan, Lütfi ^a   Akaci, Okan ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Children; Hodgkin disease; Late effect

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; PREDNISOLONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CHILD; ECHOGRAPHY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; RADIATION EXPOSURE; RETROSPECTIVE STUDY; SIDE EFFECT; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HODGKIN DISEASE; HUMANS; MALE; RADIATION INJURIES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; THYROID FUNCTION TESTS; THYROID GLAND; THYROID NODULE; TURKEY;

EID: 79959187592     PISSN: 13085727     EISSN: 13085735     Source Type: Journal    
DOI: 10.4274/jcrpe.v3i2.18     Document Type: Article

References (26)

1. th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p.695-721.
2. Lanzkowsky P. Manuel of pediatric hematology and oncology. 4th ed. Burlington: Elsevier Academic Press; 2005;453-490.
3. Büyükpamukçu M, Atahan L, Caǧlar M, Kutluk T, Akyüz C, Hazar V. Hodgkin's disease in Turkish children: clinical characteristics and treatment results of 210 patients. Pediatr Hematol Oncol 1999;16:119-129.
4. Oguz A, Karadeniz C, Okur FV, Citak EC, Pinarli FG, Bora H, Akyurek N. Prognostic factors and treatment outcome in childhood Hodgkin disease. Pediatr Blood Cancer 2005;45: 670-675.
5. Ertem U, Duru F, Daǧdemir A, Taçyildiz N, Pamir A, Akçayöz A, Uluoǧlu O, Teziç T. Hodgkin's disease in 82 Turkish children diagnosed over a 10 year period: epidemiological, clinical, and histopathologic features and prognosis with prolonged chemotherapy. Pediatr Hematol Oncol 1997;14:359-366.
6. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, Greffe B, Wolden S, Robison L. Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2000;85: 3227-3232.
7. Gold DG, Neglia JP, Dusenbery KE. Second neoplasms after megavoltage radiation for pediatric tumors. Cancer 2003;97:2588-2596.
8. Barrera M, Shaw AK, Speechley KN, Maunsell E, Pogany L. Educational and social late effects of childhood cancer and related clinical, personal, and familial characteristics. Cancer 2005;104:1751-1760.
9. Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y, Inskip PD. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 2009;27:2356-2362.
10. th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p.1490-1514.
11. Schellong G, Pötter R, Brämswig J, Wagner W, Prott FJ, Dörffel W, Körholz D, Mann G, Rath B, Reiter A, Weissbach G, Riepenhausen M, Thiemann M, Schwarze EW. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. J Clin Oncol 1999;17:3736-3744.
12. Acharya S, Sarafoglou K, LaQuaglia M, Lindsley S, Gerald W, Wollner N, Tan C, Sklar C. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer 2003;97:2397-2403.
13. Gözdasoglu S, Cavdar AO, Babacan E, Mengübas K, Yavuz G, Unal E, Pamir A, Ocal G, Haluk Gökçora I. Late effects of chemoradiotherapy in pediatric Hodgkin's disease. J Chemother 1995;7:463-466.
14. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
15. von der Weid NX. Adult life after surviving lymphoma in childhood. Support Care Cancer 2008;16:339-345.
16. Aleman BM, van den Belt-Dusebout AW, Klokman WJ, Van't Veer MB, Bartelink H, van Leeuwen FE. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003;21:3431-3439.
17. Shafford EA, Kingston JE, Healy JC, Webb JA, Plowman PN, Reznek RH. Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin's disease. Br J Cancer 1999;80:808-814.
18. Hunger SP, Link MP, Donaldson SS. ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. J Clin Oncol 1994;12:2160-2166.
19. Nair N, Advani SH. Follow up of alterations in thyroid hormones and thyrotropin in patients of Hodgkin's diseasegiven mantle radiation. J Assoc Physicians India 1990;38:623-624.
20. Moryl-Bujakowska A, Balwierz W, Sztefko K. [Preliminary results of thyroid function assessment in children and adolescents with Hodgkin's disease (HD) treated according to PGP-HD-97 protocol]. Przegl Lek 2004;61:81-84.
21. Constine LS, Donaldson SS, McDougall IR, Cox RS, Link MP, Kaplan HS. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 1984;53:878-883.
22. Lin HM, Teitell MA. Second malignancy after treatment of pediatric Hodgkin disease. J Pediatr Hematol Oncol 2005;27:28-36.
23. Bhatia S, Yasui Y, Robison LL, Birch JM, Bogue MK, Diller L, DeLaat C, Fossati-Bellani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak J, Meadows AT; Late Effects Study Group. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 2003;21: 4386-4394.
24. Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N. Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose. Int J Radiat Oncol Biol Phys 2008;72:24-33.
25. Capra M, Hewitt M, Radford M, Hayward J, Weston CL, Machin D; Children's Cancer and Leukaemia Group. Long-term outcome in children with Hodgkin's lymphoma: the United Kingdom Children's Cancer Study Group HD82 trial. Eur J Cancer 2007;43:1171-1179.
26. Metzger ML, Howard SC, Hudson MM, Gow KW, Li CS, Krasin MJ, Merchant T, Kun L, Shelso J, Pui CH, Shochat SJ, McCarville MB. Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma. Pediatr Blood Cancer 2006;46:314-319.